Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China · Delayed Price · Currency is CNY 41.30
+1.50 (3.77%)
Oct 29, 2026, 3:04 PM CST
SHE:002422 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 65,685 | 46,689 | 47,480 | 42,829 | 37,335 | 26,621 | |
Market Cap Growth | 18.96% | -1.67% | 10.86% | 14.71% | 40.25% | -4.25% |
Enterprise Value | 64,813 | 47,890 | 49,788 | 47,019 | 45,807 | 36,189 |
Last Close Price | 39.80 | 28.86 | 28.95 | 27.20 | 24.41 | 16.96 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 33.28 | 27.43 | 16.17 | 17.44 | 21.89 | 24.15 |
Forward PE | 26.32 | 23.59 | 15.69 | 21.36 | 21.81 | 18.84 |
PS Ratio | 3.45 | 2.52 | 2.18 | 2.00 | 1.96 | 1.54 |
PB Ratio | 1.96 | 1.59 | 1.78 | 1.86 | 2.21 | 1.88 |
P/TBV Ratio | 2.56 | 2.04 | 2.24 | 2.34 | 2.59 | 2.10 |
P/FCF Ratio | 27.62 | 45.79 | 16.87 | 12.00 | 16.74 | 14.34 |
P/OCF Ratio | 17.13 | 17.67 | 10.57 | 8.03 | 11.94 | 9.35 |
PEG Ratio | - | 1.97 | 0.80 | 0.80 | 0.80 | 0.80 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.40 | 2.59 | 2.28 | 2.19 | 2.41 | 2.10 |
EV/EBITDA Ratio | 19.97 | 14.10 | 9.49 | 10.23 | 13.41 | 13.45 |
EV/EBIT Ratio | 37.80 | 22.75 | 12.31 | 13.80 | 20.27 | 24.39 |
EV/FCF Ratio | 27.24 | 46.97 | 17.69 | 13.18 | 20.54 | 19.49 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.12 | 0.14 | 0.16 | 0.31 | 0.67 | 0.84 |
Debt / EBITDA Ratio | 1.20 | 1.21 | 0.79 | 1.54 | 3.28 | 4.41 |
Debt / FCF Ratio | 1.64 | 4.13 | 1.50 | 2.00 | 5.06 | 6.42 |
Net Debt / Equity Ratio | -0.22 | -0.13 | -0.08 | 0.01 | 0.36 | 0.61 |
Net Debt / EBITDA Ratio | -2.41 | -1.15 | -0.43 | 0.04 | 1.79 | 3.21 |
Net Debt / FCF Ratio | -3.16 | -3.84 | -0.80 | 0.05 | 2.74 | 4.65 |
Asset Turnover | 0.44 | 0.48 | 0.59 | 0.61 | 0.58 | 0.54 |
Inventory Turnover | 2.55 | 2.55 | 2.78 | 2.92 | 2.76 | 2.34 |
Quick Ratio | 1.74 | 1.55 | 1.39 | 1.32 | 1.04 | 0.74 |
Current Ratio | 2.45 | 2.18 | 1.96 | 1.83 | 1.38 | 1.05 |
Return on Equity (ROE) | 7.89% | 6.70% | 13.51% | 13.27% | 11.00% | 6.17% |
Return on Assets (ROA) | 2.48% | 3.41% | 6.85% | 6.03% | 4.30% | 2.92% |
Return on Invested Capital (ROIC) | 5.81% | 6.59% | 13.30% | 10.90% | 8.14% | 4.75% |
Return on Capital Employed (ROCE) | 4.90% | 6.90% | 14.40% | 12.90% | 10.20% | 8.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 3.01% | 3.65% | 6.18% | 5.73% | 4.57% | 4.14% |
FCF Yield | 3.62% | 2.18% | 5.93% | 8.33% | 5.97% | 6.97% |
Dividend Yield | 1.44% | 2.02% | 2.56% | 2.78% | 2.33% | 2.25% |
Payout Ratio | 51.08% | 64.09% | 61.70% | 45.87% | 60.60% | 90.33% |
Buyback Yield / Dilution | 0.80% | -0.77% | -2.18% | -4.17% | -4.91% | 1.15% |
Total Shareholder Return | 2.25% | 1.25% | 0.37% | -1.39% | -2.58% | 3.40% |